癌症女性的生育力保存
Fertility preservation in women with cancer.
作者信息
Lee Sanghoon, Song Jae Yun, Ku Seung Yup, Kim Sun Haeng, Kim Tak
机构信息
Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea.
出版信息
Clin Exp Reprod Med. 2012 Jun;39(2):46-51. doi: 10.5653/cerm.2012.39.2.46. Epub 2012 Jun 30.
Abstract
Fertility preservation (FP) is an effort to retain the fertility of cancer patients, and as an emerging discipline, it plays a central role in cancer care. Because of improvement in diagnostic and therapeutic strategies, an increasingly large number of patients are surviving with cancer. FP specialists should make an effort to spread the significance of FP among reproductive women with cancer and provide appropriate education both for associated physicians and for cancer patients who wish to preserve their fertility. Physicians who take part in the initial diagnosis and management of cancer should consider the importance of early referral of young cancer patients to FP specialists and take care of those patients by providing timely information and appropriate counseling. Individualized treatment strategies should be delivered depending on the patient's situation with appropriate team approach.
摘要
生育力保存（FP）是一项旨在保留癌症患者生育能力的举措，作为一门新兴学科，它在癌症治疗中发挥着核心作用。由于诊断和治疗策略的改进，越来越多的癌症患者得以存活。FP专家应努力向患有癌症的育龄女性传播FP的重要性，并为相关医生以及希望保留生育能力的癌症患者提供适当的教育。参与癌症初始诊断和治疗的医生应考虑将年轻癌症患者尽早转诊给FP专家的重要性，并通过提供及时的信息和适当的咨询来照顾这些患者。应根据患者的情况，采用适当的团队协作方式提供个性化的治疗策略。
相似文献
1
Fertility preservation in women with cancer.
Clin Exp Reprod Med. 2012 Jun;39(2):46-51. doi: 10.5653/cerm.2012.39.2.46. Epub 2012 Jun 30.
2
Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.
Clin Exp Reprod Med. 2017 Dec;44(4):175-180. doi: 10.5653/cerm.2017.44.4.175. Epub 2017 Dec 31.
3
Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines.
Clin Exp Reprod Med. 2017 Dec;44(4):171-174. doi: 10.5653/cerm.2017.44.4.171. Epub 2017 Dec 31.
4
Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation.
Hum Reprod. 2019 Sep 29;34(9):1726-1734. doi: 10.1093/humrep/dez136.
5
Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.
Hum Reprod. 2015 Jul;30(7):1625-34. doi: 10.1093/humrep/dev116. Epub 2015 Jun 1.
6
Expanding Urgent Oncofertility Services for Reproductive Age Women Remote from a Tertiary Level Fertility Centre by Use of Telemedicine and an On-site Nurse Navigator.
J Cancer Educ. 2020 Jun;35(3):515-521. doi: 10.1007/s13187-019-01490-w.
7
Fertility preservation in the male pediatric population: factors influencing the decision of parents and children.
Hum Reprod. 2015 Sep;30(9):2022-30. doi: 10.1093/humrep/dev161. Epub 2015 Jul 3.
8
Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors.
J Cancer Surviv. 2012 Sep;6(3):324-32. doi: 10.1007/s11764-012-0227-9. Epub 2012 Jul 3.
9
A Study Protocol for the Australasian Oncofertility Registry: Monitoring Referral Patterns and the Uptake, Quality, and Complications of Fertility Preservation Strategies in Australia and New Zealand.
J Adolesc Young Adult Oncol. 2016 Sep;5(3):215-25. doi: 10.1089/jayao.2015.0062. Epub 2016 Mar 16.
10
What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
Hum Reprod Update. 2017 Jul 1;23(4):433-457. doi: 10.1093/humupd/dmx009.
引用本文的文献
1
Role of Klotho as a Modulator of Oxidative Stress Associated with Ovarian Tissue Cryopreservation.
Int J Mol Sci. 2021 Dec 17;22(24):13547. doi: 10.3390/ijms222413547.
2
Role of Stem Cells in the Ovarian Tissue Cryopreservation and Transplantation for Fertility Preservation.
Int J Mol Sci. 2021 Nov 19;22(22):12482. doi: 10.3390/ijms222212482.
3
Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation.
Genes (Basel). 2021 Sep 28;12(10):1525. doi: 10.3390/genes12101525.
4
Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Int J Mol Sci. 2021 Jul 13;22(14):7484. doi: 10.3390/ijms22147484.
5
Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients.
Reprod Sci. 2021 Jun;28(6):1746-1758. doi: 10.1007/s43032-021-00517-2. Epub 2021 Mar 31.
6
Changes in telomere length and senescence markers during human ovarian tissue cryopreservation.
Sci Rep. 2021 Jan 26;11(1):2238. doi: 10.1038/s41598-021-81973-3.
7
Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Int J Mol Sci. 2020 Oct 21;21(20):7792. doi: 10.3390/ijms21207792.
8
Comparison between Slow Freezing and Vitrification for Human Ovarian Tissue Cryopreservation and Xenotransplantation.
Int J Mol Sci. 2019 Jul 8;20(13):3346. doi: 10.3390/ijms20133346.
9
Ovarian tissue cryopreservation and transplantation in patients with cancer.
Obstet Gynecol Sci. 2018 Jul;61(4):431-442. doi: 10.5468/ogs.2018.61.4.431. Epub 2018 Jun 28.
10
Successful Spontaneous Pregnancy after Treatment for Ewing Sarcoma including Sacrectomy.
Case Rep Obstet Gynecol. 2018 Apr 30;2018:2484036. doi: 10.1155/2018/2484036. eCollection 2018.
本文引用的文献
1
Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?
Fertil Steril. 2012 Oct;98(4):961-4.e1. doi: 10.1016/j.fertnstert.2012.06.015. Epub 2012 Jul 6.
2
Sex differences in fertility-related information received by young adult cancer survivors.
J Clin Oncol. 2012 Jun 10;30(17):2147-53. doi: 10.1200/JCO.2011.40.6470. Epub 2012 May 14.
3
Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy.
Fertil Steril. 2012 Jun;97(6):1387-93.e1-2. doi: 10.1016/j.fertnstert.2012.02.052. Epub 2012 Mar 30.
4
Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women.
Nat Med. 2012 Feb 26;18(3):413-21. doi: 10.1038/nm.2669.
5
Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy?
J Clin Oncol. 2012 Feb 10;30(5):479-81. doi: 10.1200/JCO.2011.37.9883. Epub 2012 Jan 9.
6
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
J Clin Oncol. 2012 Feb 10;30(5):533-8. doi: 10.1200/JCO.2011.34.6890. Epub 2012 Jan 9.
7
Ovary cryopreservation and transplantation for fertility preservation.
Mol Hum Reprod. 2012 Feb;18(2):59-67. doi: 10.1093/molehr/gar082. Epub 2011 Dec 28.
8
Options on fertility preservation in female cancer patients.
Cancer Treat Rev. 2012 Aug;38(5):354-61. doi: 10.1016/j.ctrv.2011.10.002. Epub 2011 Nov 9.
9
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
JAMA. 2011 Jul 20;306(3):269-76. doi: 10.1001/jama.2011.991.
10
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.
J Clin Oncol. 2011 Jun 10;29(17):2334-41. doi: 10.1200/JCO.2010.32.5704. Epub 2011 May 2.
Zotero 插件